Chemotherapy News and Research

Latest Chemotherapy News and Research

Combination therapy shows promising results in patients with recurrent ER-positive endometrial cancer

A combination therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in 75% of patients with recurrent or persistent estrogen receptor- (ER-) positive endometrial cancer, results from a recent clinical trial show.

19 Mar 2022

Novel metabolic mechanisms contribute to how ovarian cancer evades immune attack, research finds

High-grade serous carcinoma is the most aggressive form of ovarian cancer and accounts for the majority of advanced-stage cases.

16 Mar 2022

Yale researchers uncover how to control the blood-brain barrier with a molecule

The brain is composed of billions of neurons - vulnerable cells that require a protective environment to function properly.

16 Mar 2022

Nanoparticle-enhanced phototherapies for cancer treatment

Treating cancer and other diseases with laser light is not currently considered routine in the clinical setting, but new approaches using nanoparticles show some promise in improving existing techniques.

15 Mar 2022

Anti-spike IgG dynamics after 2nd BNT162b2 COVID-19 vaccine dose in Japanese health care workers

Researchers investigate the dynamics of anti-spike IgG levels against the SARS-CoV-2 spike protein in Japanese healthcare workers.

15 Mar 2022

Survey reveals severe shortage of pharmacy technicians in hospitals and health systems

Hospitals and health systems are experiencing severe shortages of pharmacy technicians, with a majority of pharmacy administrators in a recent survey reporting turnover rates of at least 21% in 2021, and nearly 1 in 10 noting they had lost 41% or more of their technicians.

15 Mar 2022

Research findings may explain marked racial disparity in deaths from triple negative breast cancer

Different activity in two molecular networks could help explain why triple negative breast cancers tend to be more aggressive in African American (AA) women compared with white American (WA) women, a new study led by Johns Hopkins Kimmel Cancer Center researchers suggests.

15 Mar 2022

Study raises hopes for effective treatment of infant B acute lymphoblastic leukemia

New research has begun to unravel the mystery of why a particular form of leukemia in infants has defied efforts to improve outcomes, despite significant improvements in treating older children.

14 Mar 2022

Malaria drug could help treat chemotherapy-resistant head and neck cancers

A new study suggests that the malaria drug hydroxychloroquine inhibits pathways that drive resistance to the chemotherapy agent cisplatin in head and neck cancers and restores tumor-killing effects of cisplatin in animal models.

14 Mar 2022

Lower, more frequent doses of nanomedicines may provide additional benefits for cancer patients

Tiny structures called nanoparticles can be used to carry substances to certain parts of the body - for example, to deliver a chemotherapy drug to a tumor.

11 Mar 2022

Ribociclib plus endocrine therapy offers survival benefit for postmenopausal patients with metastatic breast cancer

A study led by researchers from The University of Texas MD Anderson Cancer Center showed a significant overall survival benefit with ribociclib plus endocrine therapy for postmenopausal patients with hormone receptor-positive (HR+) human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer.

10 Mar 2022

New study analyzes COVID-19 outcomes in patients with cancer

If a cancer patient tests positive for COVID-19, are they more likely to become hospitalized from the disease?

10 Mar 2022

Using metal oxide nanoparticles as 'radiosensitizers' for gentler cancer treatment

Radiation therapy is one of the cornerstones of cancer therapy. However, some types of tumor respond little or hardly at all to radiation. If it were possible to make tumor cells more sensitive, treatment would be more effective and gentler.

10 Mar 2022

Researchers exploit cancer cells' appetite for iron to treat tough tumors

Researchers at the University of California, San Francisco, have successfully leveraged an FDA-approved drug to halt growth of tumors driven by mutations in the RAS gene, which are famously difficult to treat and account for about one in four cancer deaths.

9 Mar 2022

NCCN publishes new resources for treating rare tumor types

The National Comprehensive Cancer Network - an alliance of leading cancer centers - today announced the publication of new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Ampullary Adenocarcinoma.

9 Mar 2022

Novel radioligand therapy shown to increase survival of metastatic prostate cancer patients

A novel prostate cancer treatment - 225Ac-PSMA-617 radioligand therapy - has been shown to increase the progression free survival (PFS) and overall survival (OS) of metastatic castration-resistant prostate cancer (mCRPC) patients, according to research published by The Journal of Nuclear Medicine.

9 Mar 2022

Study explores immune escape mutations caused by prolonged viral shedding in immunocompromised COVID-19 patient

A new study examined a unique case of extended viral shedding in an immunocompromised patient that produced a series of SARS-CoV-2 immune escape mutations over a seven-month period.

8 Mar 2022

Insurance status and residential zip codes linked with survival among breast cancer patients

Recent findings published in JAMA Oncology found that individual insurance status and residential zip codes were correlated with overall survival among women with early hormone receptor-positive breast cancer.

8 Mar 2022

Some blood cells remain in tissues for years, research finds

Human immune cells not only circulate in the blood, but can also occupy certain tissues and sometimes remain there for years.

7 Mar 2022

Researchers examine how structural violence can set the stage for poorer leukemia outcomes

Black and Hispanic people with acute myeloid leukemia in greater Chicago were more likely to die from the disease than their non-Hispanic white counterparts, with a 59% and 25% greater risk, respectively, according to a new study led by University of Illinois Chicago researchers.

7 Mar 2022

Chemotherapy News and Research

Latest Chemotherapy News and Research

Combination therapy shows promising results in patients with recurrent ER-positive endometrial cancer

Novel metabolic mechanisms contribute to how ovarian cancer evades immune attack, research finds

Yale researchers uncover how to control the blood-brain barrier with a molecule

Nanoparticle-enhanced phototherapies for cancer treatment

Anti-spike IgG dynamics after 2nd BNT162b2 COVID-19 vaccine dose in Japanese health care workers

Survey reveals severe shortage of pharmacy technicians in hospitals and health systems

Research findings may explain marked racial disparity in deaths from triple negative breast cancer

Study raises hopes for effective treatment of infant B acute lymphoblastic leukemia

Malaria drug could help treat chemotherapy-resistant head and neck cancers

Lower, more frequent doses of nanomedicines may provide additional benefits for cancer patients

Ribociclib plus endocrine therapy offers survival benefit for postmenopausal patients with metastatic breast cancer

New study analyzes COVID-19 outcomes in patients with cancer

Using metal oxide nanoparticles as 'radiosensitizers' for gentler cancer treatment

Researchers exploit cancer cells' appetite for iron to treat tough tumors

NCCN publishes new resources for treating rare tumor types

Novel radioligand therapy shown to increase survival of metastatic prostate cancer patients

Study explores immune escape mutations caused by prolonged viral shedding in immunocompromised COVID-19 patient

Insurance status and residential zip codes linked with survival among breast cancer patients

Some blood cells remain in tissues for years, research finds

Researchers examine how structural violence can set the stage for poorer leukemia outcomes

Cancer Research - Second Edition eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in